Agreed hankmanhub. I dont think its realistic for the current management to take it all the way through (Including DCVax direct). If I am not mistaken, the core of our management are into their 70's, I think if the right price is offered they'd be more than willing for a buyout.
With an increasing amount of pointers towards efficacy, and with immunotherapy becoming a priority for BP, i am sure something so go will be snapped up easily. Just hope for the sake of us investors, its soon, and we dont have to undergo anxiety during the volatily. Asking for too much I suppose :)
Market Data 
Markets 
AI
